The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Keywords: 4F-benzoyl-TN14003; AMD3100; AMD3100-Based Non-Cyclam Compounds; CXCL12; CXCR4; Dipicolylamine zinc(II)-Based Compounds; Epstein-Barr virus-encoded; G-protein coupled receptor (GPCR); HIV-1; HSEFFR-CPC-RFFESH; Limulus polyphemus; Linear T140-Based Oligopeptides; T-140-Based Cyclic Pentapeptides; TC14012; TN14003; TZ14004; Tachypleus tridentatus; aberrant hematopoiesi; agonist; analogue; angiogenesis; antagonist; bone marrow; brain; cancer; chemokine receptors; cognate ligand; hematopoietic progenitor mobilization; homodimerization; human immunodeficiency virus type 1; liver; lung; lymph nodes; p-fluorobenzoylated tripeptide mimetics; peptide; peptide inhibitors; tripeptide mimetics
Document Type: Research Article
Publication date: 2011-02-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.